| Cover | Dec. 19, 2023 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Dec. 19, 2023 |
| Entity File Number | 001-39685 |
| Entity Registrant Name | InMed Pharmaceuticals Inc. |
| Entity Central Index Key | 0001728328 |
| Entity Tax Identification Number | 98-1428279 |
| Entity Incorporation, State or Country Code | A1 |
| Entity Address, Address Line One | Suite 310 - 815 W. Hastings Street, |
| Entity Address, City or Town | Vancouver |
| Entity Address, State or Province | BC |
| Entity Address, Country | CA |
| Entity Address, Postal Zip Code | V6C 1B4 |
| City Area Code | 604 |
| Local Phone Number | 669-7207 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Shares, no par value |
| Trading Symbol | INM |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
